153 related articles for article (PubMed ID: 2797459)
1. Diagnostic significance of IgG, C3, and C9 at the limb muscle motor end-plate in minimal myasthenia gravis.
Tsujihata M; Yoshimura T; Satoh A; Kinoshita I; Matsuo H; Mori M; Nagataki S
Neurology; 1989 Oct; 39(10):1359-63. PubMed ID: 2797459
[TBL] [Abstract][Full Text] [Related]
2. Passively transferred experimental autoimmune myasthenia gravis. Sequential and quantitative study of the motor end-plate fine structure and ultrastructural localization of immune complexes (IgG and C3), and of the acetylcholine receptor.
Engel AG; Sakakibara H; Sahashi K; Lindstrom JM; Lambert EH; Lennon VA
Neurology; 1979 Feb; 29(2):179-88. PubMed ID: 571062
[TBL] [Abstract][Full Text] [Related]
3. [Study of antibodies to motor end-plate in ocular myasthenia gravis].
Kinoshita I; Tsujihata M; Motomura M; Yoshimura T; Nagataki S
Rinsho Shinkeigaku; 1991 May; 31(5):500-4. PubMed ID: 1934762
[TBL] [Abstract][Full Text] [Related]
4. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations.
Engel AG; Lambert EH; Howard FM
Mayo Clin Proc; 1977 May; 52(5):267-80. PubMed ID: 870771
[TBL] [Abstract][Full Text] [Related]
5. The immunopathological basis of acetylcholine receptor deficiency in myasthenia gravis.
Engel AG
Prog Brain Res; 1979; 49():423-34. PubMed ID: 515440
[No Abstract] [Full Text] [Related]
6. Structure-function correlations in myasthenia gravis and a new myasthenic syndrome.
Engel AG; Lambert EH
Electroencephalogr Clin Neurophysiol Suppl; 1978; (34):469-77. PubMed ID: 220007
[TBL] [Abstract][Full Text] [Related]
7. The immunopathology of acquired myasthenia gravis.
Engel AG; Sahashi K; Fumagalli G
Ann N Y Acad Sci; 1981; 377():158-74. PubMed ID: 6951470
[TBL] [Abstract][Full Text] [Related]
8. Ultrastructural localization of immune complexes (IgG and C3) at the end-plate in experimental autoimmune myasthenia gravis.
Sahashi K; Engel AG; Linstrom JM; Lambert EH; Lennon VA
J Neuropathol Exp Neurol; 1978; 37(2):212-23. PubMed ID: 147324
[TBL] [Abstract][Full Text] [Related]
9. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of immune complexes at the motor endplate in myasthenia gravis].
Tsujihata M; Yoshimura T; Satoh A; Hazama R; Mori M
Rinsho Shinkeigaku; 1983 Sep; 23(9):735-43. PubMed ID: 6673871
[No Abstract] [Full Text] [Related]
11. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
Shiraishi H; Motomura M; Yoshimura T; Fukudome T; Fukuda T; Nakao Y; Tsujihata M; Vincent A; Eguchi K
Ann Neurol; 2005 Feb; 57(2):289-93. PubMed ID: 15668981
[TBL] [Abstract][Full Text] [Related]
12. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
[TBL] [Abstract][Full Text] [Related]
13. Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity.
Mossman S; Vincent A; Newsom-Davis J
Lancet; 1986 Jan; 1(8473):116-9. PubMed ID: 2417076
[TBL] [Abstract][Full Text] [Related]
14. Semiquantitative measurement of acetylcholine receptor at the motor end-plate in myasthenia gravis.
Tsujihata M; Ito H; Satoh A; Yoshimura T; Motomura M; Nakamura T
Intern Med; 2001 May; 40(5):376-81. PubMed ID: 11393405
[TBL] [Abstract][Full Text] [Related]
15. Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange.
Newsom-Davis J; Pinching AJ; Vincent A; Wilson SG
Neurology; 1978 Mar; 28(3):266-72. PubMed ID: 564482
[TBL] [Abstract][Full Text] [Related]
16. Acquired canine myasthenia gravis: immunocytochemical localization of immune complexes at neuromuscular junctions.
Pflugfelder CM; Cardinet GH; Lutz H; Holliday TA; Hansen RJ
Muscle Nerve; 1981; 4(4):289-95. PubMed ID: 7019698
[TBL] [Abstract][Full Text] [Related]
17. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
[TBL] [Abstract][Full Text] [Related]
18. Current concepts of pathogenesis and treatment of myasthenia gravis.
Elias SB; Appel SH
Med Clin North Am; 1979 Jul; 63(4):745-57. PubMed ID: 89275
[No Abstract] [Full Text] [Related]
19. Myasthenia gravis: relation between jitter in single-fiber EMG and antibody to acetylcholine receptor.
Konishi T; Nishitani H; Matsubara F; Ohta M
Neurology; 1981 Apr; 31(4):386-92. PubMed ID: 6261187
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic difficulties in myasthenia gravis.
Maher J; Grand'Maison F; Nicolle MW; Strong MJ; Bolton CF
Muscle Nerve; 1998 May; 21(5):577-83. PubMed ID: 9572236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
